findmyKOL

Heather Ferris, MD, PhD

Basic profile

University of Virginia

ORCIDNPI
RegionCharlottesville, VA · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2016–2026Why? →

Heather Ferris is an Endocrinology/Metabolic physician affiliated with University of Virginia. OpenAlex indexes 68 publications with 2,850 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
68publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,850citations

Total citations across indexed works.

23h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
4NIH grants · 2016–2026

Federally funded research awards.

View funding

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    76.2%
    GLP-1 receptor agonist26.1%
    Ozempic46%Trulicity44%Mounjaro11%
    Part D<11 patients
    Insulin Analog15.5%
    Lantus Solostar58%Novolog Flexpen19%Toujeo Solostar12%Novolog11%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    13.4%
    Statin5.7%
    Atorvastatin Calcium59%Rosuvastatin Calcium41%
    Part D<11 patients
    ACE inhibitor2.2%
    Lisinopril100%
    Part D<11 patients

    + 3 more classes in this area

  • Hormonal (systemic)

    6%
    l-Thyroxine6%
    Levothyroxine Sodium100%
    Part D13 patients
Where care is delivered (Part B)27.5% facility · 72.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 20162026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”